Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett's oesophagus: a case-control study.
about
Non-Alcoholic Fatty Liver Disease and Extra-Hepatic CancersGender difference in gastro-esophageal reflux diseasesGastro-esophageal reflux disease and obesity, where is the link?Barrett's oesophagus: frequency and prediction of dysplasia and cancerSegmentation and quantification of adipose tissue by magnetic resonance imaging.A multibiomarker risk score helps predict risk for Barrett's esophagus.Symptomatic reflux disease: the present, the past and the future.Barrett's esophagus and cancer risk: how research advances can impact clinical practice.The role of obesity in oesophageal cancer development.Pathophysiological mechanisms linking obesity and esophageal adenocarcinomaRepublished: symptomatic reflux disease: the present, the past and the future.The effect of abdominal visceral fat, circulating inflammatory cytokines, and leptin levels on reflux esophagitis.Effect of body mass index and intra-abdominal fat measured by computed tomography on the risk of bowel symptomsRisk factors affecting the Barrett's metaplasia-dysplasia-neoplasia sequence.Association of Visceral Fat Area, Smoking, and Alcohol Consumption with Reflux Esophagitis and Barrett's Esophagus in Japan.Metabolic syndrome and the risk of Barrett's oesophagus in white males.Risk Profiles for Barrett's Esophagus Differ between New and Prevalent, and Long- and Short-Segment CasesRole of body composition and metabolic profile in Barrett's oesophagus and progression to cancer.Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis.Circulating inflammatory cytokines and adipokines are associated with increased risk of Barrett's esophagus: a case-control studyObesity and GERD.Epidemiology and risk factors for Barrett's oesophagus.Contribution of immunomodulators to gastroesophageal reflux disease and its complications: stromal cells, interleukin 4, and adiponectin.Waist to hip ratio is a better predictor of esophageal acid exposure than body mass index.Two distinct etiologies of gastric cardia adenocarcinoma: interactions among pH, Helicobacter pylori, and bile acids.Risk factors for Barrett's esophagus.General and abdominal obesity and risk of esophageal and gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition.Clinical characteristics of patients with diabetes mellitus and fatty liver diagnosed by liver/spleen Hounsfield units on CT scanLetter: should Barrett's oesophagus be considered a potential cardiovascular risk factor?Association of sporadic and familial Barrett's esophagus with breast cancer.Visceral adiposity is associated with an increased risk of functional dyspepsia.Total body fat and the risk of Barrett's oesophagus - a bioelectrical impedance study.Environmentally Induced Alterations in the Epigenome Affecting Obesity and Cancer in Minority Populations
P2860
Q26749045-FCA60DE2-AC8C-41F4-AF93-9099174D3CABQ26768413-6188E17A-EBBB-4FCC-8CD4-C3C11905C21DQ27011551-CF9CA881-D10F-44F5-83D9-50EFA675A060Q28080794-62E77E8F-D869-4F03-B396-8D394D24BAB9Q30991409-A0BFEAD9-2A8A-4364-BE0C-67A4F891D592Q33779408-605C3238-A24C-4BC3-B42A-A168A095313DQ33834731-BA8A1E49-EA74-461F-BD7E-CAC712A51499Q33959620-FF088C50-4DF3-4EBE-ABE2-78736735C836Q34418740-BF8860A6-913E-4157-9C17-27FAD1686439Q34508880-37F30466-8BB2-483B-8072-A6359EEE9F19Q35048270-9783DB63-F1AB-4CA7-9B49-AE020E379E6AQ35430561-84551FB2-9465-4397-994E-3FDB72BF7B78Q35533087-052E2A59-C961-4100-9EDC-7B5459894F33Q35622201-75B6FB0F-EE79-404B-AC04-B39229F4362BQ35726219-8D13C6F6-127E-4A21-B27F-919BA2877E1DQ35880694-88CC9CBB-C20E-41B1-9205-489F83651B79Q36236462-E0E4EDF2-6D04-4801-A3A1-D123CCBD8981Q36538457-3480FE84-81D1-4C56-BAC8-223B5FBBA624Q37416283-E3822483-8B79-4A11-A66A-C33326252577Q37505223-7139B55A-833D-4474-B3F8-7AA1659183D3Q37576268-02ED3F31-D09F-4DFA-BD63-211178214F98Q38374209-A16F7F93-8400-46CE-AFF2-45D781424514Q38904116-C4B22033-BB4F-43E8-9AF3-6F29209C513CQ38992710-CE4237E8-3F10-4F8D-9F46-F81FC29BF09AQ40515408-6A040BD2-E171-45AC-8C29-AC3F6537DE6FQ40879184-E894076B-6236-4A29-BC3A-C4AEEB4802AEQ41566014-483FD0C4-E480-405E-B790-461AA462CE19Q42089836-74E9FB9E-281E-48B4-A913-25C5B374F7ADQ48315859-E5565BA2-D4F3-4A79-BE50-B521DAA9C986Q52661117-1DCEF1F1-438C-4A14-863C-1F2CE9813D71Q53365175-B1E3E7AE-4D86-49EA-8111-7E4EB1EABBF9Q55664161-DBD573A8-38B2-4AA7-A7ED-C7B37F712D4DQ57433696-F84DB062-443F-48F4-B1CF-530382DA6AE4
P2860
Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett's oesophagus: a case-control study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 February 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Visceral abdominal obesity mea ...... ophagus: a case-control study.
@en
Visceral abdominal obesity mea ...... ophagus: a case-control study.
@nl
type
label
Visceral abdominal obesity mea ...... ophagus: a case-control study.
@en
Visceral abdominal obesity mea ...... ophagus: a case-control study.
@nl
prefLabel
Visceral abdominal obesity mea ...... ophagus: a case-control study.
@en
Visceral abdominal obesity mea ...... ophagus: a case-control study.
@nl
P2093
P2860
P1433
P1476
Visceral abdominal obesity mea ...... ophagus: a case-control study.
@en
P2093
Abeer Alsarraj
Ali Hashmi
Bhupinderjit Anand
Hashem B El-Serag
Jennifer R Kramer
Jose Garcia
Marcelo Vela
Margot B Rodriguez
Maria Velez
Neena S Abraham
P2860
P304
P356
10.1136/GUTJNL-2012-304189
P407
P577
2013-02-13T00:00:00Z